Protective Antibody Level After COVID-19 Vaccination Among Patients Under Hemodialysis

Completed

• Conditions: Hemolysis; Vaccine Reaction; Covid19; End-stage Renal Disease

• Registration Number: NCT04871945
• Lead Sponsor: Hanyang University Seoul Hospital

Brief Summary

The aim of the study is to evaluate the level of neutralizing antibody against SARS-CoV-2 after COVID-19 vaccination in patients under hemodialysis. To this end, the level of neutralizing antibody of patients under hemodialysis is compared to that of healthy population.

Detailed Description

Not available

Study Timeline

• Status Verified: 2021-03
• Study Start: 2021-04-20
• Study First Submitted: 2021-04-29
• Study First Submitted QC: 2021-04-30
• Study First Posted: 2021-05-04
• Primary Completion: 2021-09-30
• Study Completion: 2021-10-31
• Last Update Submitted: 2022-03-16
• Last Update Posted: 2022-03-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 31

Inclusion Criteria

• The person who is vaccinated with ChAdOx1 (COVID-19 vaccine)
• The person who agrees with the protocol of the study

Exclusion Criteria

• Age < 18 years
• Pregnants
• Experience of COVID-19 infection

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The change in the level of neutralizing antibody against SARS-CoV-2	Day 0, 14, 28, 56, 91, 120

Trial Locations

Locations (1)

Hanyang University Seoul Hospital; 🇰🇷 Seoul, Korea, Republic of